UK Markets close in 8 hrs 16 mins

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
83.860.00 (0.00%)
As of 05:37PM CET. Market open.
Sign in to post a message.
  • J
    Jedi
    Drugmaker Sanofi raises 2021 profit guidance again after Q3 beat
  • J
    Jedi
    Sanofi Raises FY21 Earnings Outlook As Dupixent, Vaccines Boost Q3 Performance
  • q
    quaker
    Many people are seeking for stability in this unstable crypto space and A lot of people are wondering if now is a good time to buy because of where the price is at right now . I'd say it's wrong to just sit back hold and wait maybe incur some losses along the line , that's a wrong mindset for an investor because as an investor finding ways to always increase and stack up more coins thereby making profits should be the way of life that being said , the market is still all about BTC at the moment and I'll advise current investors and newbies to take advantage of the Mr. Steve program , an establishment that handles people who lack understanding on how maneuver the crypto space , to help them recover loss from the crash and also accumulate more positive returns , with their program i went from having 1.4btc to 7btc in just 9 weeks.

    if you're interested in getting started just send Steve a message on whats<<<>>App + 1 ( 8 1 3 ) 6 8 3 ‑ 6 3 1 0 OR Te** le*gram @SteveFX01
  • a
    aby
    Why is this so down? Didn't hit the Covid lottery? Is ok, to move on.
    Good time to jump in?
  • מ
    מרק
    thay need to buy biolinerx blrx if thay want to keep profits from mozobil
  • M
    Metal Ox
    $TBIO shares cashed this week by Sanofi. With mrna now in its portfolio, is $SNY worth considering, or dead money Investment? What’s the case for buying Sanofi, or is there a case?
  • s
    s
    Shall I buy ?
  • P
    Phil
    Sanofi’s Covid vaccine is now in its Phase 3 trial, yawn........
  • s
    steve
    U.S. to pay $2.1 billion to Sanofi, GSK, in COVID-19 vaccine deal
  • l
    letmebehonest
    Sanofi to open big multi vaccine manufacturing in Singapore as per local news, this is great news for Singapore and all investors....check the news feed about this info. Sanofi is the future of Bio Pharma manufactiring
  • J
    Joe
    besides the polio vaccine what French company has ever offered any good stock that makes investors money?
  • A
    ASAP
    President of the US just mentioned hydroxychloroquine ! Developed dby Sanofi and Regeneron Pharmaceuticals, Inc
  • I
    Imelda
    It will be very hard for me to buy this stock.I will always remember the dead children in the Philippines who was given the Sanofi Dengue vaccine.More than a dozen,No money could ever buy those lives back.
  • W
    Wolf.of.BayStreet
    just got funding from canadian govt to build vaccine facility in toronto. heard it here first
  • n
    nito
    Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial. $SNY, $PFE, $JNJ, $EBS, $AZN, $NVS, $GSK
    Trial also achieves statistical significance in key secondary endpoints
    Novavax to submit a U.S. BLA under FDA’s accelerated approval pathway
    Company to host investor conference call today at 8:30 a.m. EDT
    GAITHERSBURG, Md., March 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu™, its recombinant quadrivalent seasonal influenza vaccine candidate with its proprietary Matrix-M™ adjuvant, in adults aged 65 and older. Using the Food and Drug Administration’s (FDA) criteria for accelerated approval of seasonal influenza vaccines, the trial evaluated the immunogenicity and safety of NanoFlu compared to Fluzone® Quadrivalent, a U.S.-licensed quadrivalent influenza vaccine.
    https://finance.yahoo.com/news/novavax-nanoflu-achieves-primary-endpoints-100010015.html
  • M
    Madeleine
    Breaking : Ontario (CAN) to build vaccine facility
  • N
    Nuno
    I think that sanofi in undervalued. From my calculations the target price is 93#$%$ however i'm not taking into consideration the molecules pipeline and assuming that dupixent dont lose market share.Please share your opinions.This post is not a recomendation.
  • H
    H
    Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, its chief executive told Reuters on Thursday.
    Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, its chief executive told Reuters on Thursday.
    www.reuters.com
  • s
    scott
    Enrolled 150 patients - focused on high risk population. Interviewing Dr. who’s leading study on GMA now.
  • R
    Rami
    The government is looking into Hydroxychloroquine (HCQ) sold under the brand name Plaquenil as a therapeutic treatment for COVID19. Who owns Plaquenil? Yep, Sanofi.

    French pharmaceutical company Sanofi said on Wednesday that it is ready to offer the French authorities the anti-malarial drug in the fight against the new coronavirus killing thousands worldwide.
    In a recent clinical trial, the Plaquenil drug was tested on 24 patients, and after six days, the virus had disappeared in three quarters of them